Quantitation of Plasma Membrane Drug Transporters in Kidney Tissue and Cell Lines Using a Novel Proteomic Approach Enabled a Prospective Prediction of Metformin Disposition.


Journal

Drug metabolism and disposition: the biological fate of chemicals
ISSN: 1521-009X
Titre abrégé: Drug Metab Dispos
Pays: United States
ID NLM: 9421550

Informations de publication

Date de publication:
10 2021
Historique:
received: 29 03 2021
accepted: 06 07 2021
pubmed: 1 8 2021
medline: 19 3 2022
entrez: 31 7 2021
Statut: ppublish

Résumé

The successful prospective incorporation of in vitro transporter kinetics in physiologically based pharmacokinetic (PBPK) models to describe drug disposition remains challenging. Although determination of scaling factors to extrapolate in vitro to in vivo transporter kinetics has been facilitated by quantitative proteomics, no robust assessment comparing membrane recoveries between different cells/tissues has been made. HEK293 cells overexpressing OCT2, MATE1, and MATE2K or human kidney cortex were homogenized and centrifuged to obtain the total membrane fractions, which were subsequently subjected to liquid-liquid extraction followed by centrifugation and precipitation to isolate plasma membrane fractions. Plasma membrane recoveries determined by quantitation of the marker Na

Identifiants

pubmed: 34330717
pii: dmd.121.000487
doi: 10.1124/dmd.121.000487
doi:

Substances chimiques

Hypoglycemic Agents 0
Organic Cation Transport Proteins 0
Organic Cation Transporter 2 0
SLC22A2 protein, human 0
SLC47A1 protein, human 0
SLC47A2 protein, human 0
Metformin 9100L32L2N

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

938-946

Informations de copyright

Copyright © 2021 by The American Society for Pharmacology and Experimental Therapeutics.

Auteurs

Ryota Kikuchi (R)

Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois.

William J Chiou (WJ)

Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois.

Kenneth R Durbin (KR)

Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois.

John P Savaryn (JP)

Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois.

Junli Ma (J)

Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois.

Arian Emami Riedmaier (A)

Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois.

Sonia M de Morais (SM)

Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois.

Gary J Jenkins (GJ)

Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois.

Daniel A J Bow (DAJ)

Drug Metabolism and Pharmacokinetics, AbbVie Inc., North Chicago, Illinois daniel.bow@abbvie.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH